Skip to main content
NCBI home page
Molecular and Cellular Biology logoLink to Molecular and Cellular Biology
. 1983 Dec;3(12):2259–2270. doi: 10.1128/mcb.3.12.2259

Differentiation in vitro of human-mouse teratocarcinoma hybrids.

F J Benham, M V Wiles, P N Goodfellow
PMCID: PMC370097  PMID: 6686281

Abstract

The mouse embryonal carcinoma (EC) line, PCC4, was used to construct a series of somatic cell hybrids which contain a single or a few human chromosomes. The hybrids all retained the EC phenotype as determined by morphology, expression of SSEA-1, lack of cell surface H-2 antigen and cytokeratin filaments, high alkaline phosphatase levels, the ability to form EC tumors ectopically in nude mice, and the ability to differentiate in response to retinoic acid. Constitutively differentiated cloned lines were derived from retinoic acid-treated hybrid cultures. Several derived lines had a phenotype indistinguishable from that of parietal endoderm cells, which includes synthesis of large amounts of laminin, type IV procollagen, and plasminogen activator. One differentiated line showed a fibroblast-like morphology. The differentiated lines derived from two of the hybrids, MCP6 and GEOC4, stably maintained the sole human chromosomal component present in the EC progenitors. These EC hybrids therefore provide a system to study developmental regulation of the introduced and stably maintained human genetic material derived from a variety of cell types.

Full text

PDF
2259

Images in this article

2262Image
on p.2262
2263Image
on p.2263
2265Image
on p.2265
2266Image
on p.2266
2266Image
on p.2266

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adamson E. D., Evans M. J., Magrane G. G. Biochemical markers of the progress of differentiation in cloned teratocarcinoma cell lines. Eur J Biochem. 1977 Oct 3;79(2):607–615. doi: 10.1111/j.1432-1033.1977.tb11845.x. [DOI] [PubMed] [Google Scholar]
  2. Andrews P. W., Bronson D. L., Benham F., Strickland S., Knowles B. B. A comparative study of eight cell lines derived from human testicular teratocarcinoma. Int J Cancer. 1980 Sep 15;26(3):269–280. doi: 10.1002/ijc.2910260304. [DOI] [PubMed] [Google Scholar]
  3. Andrews P. W., Goodfellow P. N. Antigen expression by somatic cell hybrids of a murine embryonal carcinoma cell with thymocytes and L cells. Somatic Cell Genet. 1980 Mar;6(2):271–284. doi: 10.1007/BF01538801. [DOI] [PubMed] [Google Scholar]
  4. Arce-Gomez B., Jones E. A., Barnstable C. J., Solomon E., Bodmer W. F. The genetic control of HLA-A and B antigens in somatic cell hybrids: requirement for beta2 microglobulin. Tissue Antigens. 1978 Feb;11(2):96–112. doi: 10.1111/j.1399-0039.1978.tb01233.x. [DOI] [PubMed] [Google Scholar]
  5. Barnstable C. J., Bodmer W. F., Brown G., Galfre G., Milstein C., Williams A. F., Ziegler A. Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis. Cell. 1978 May;14(1):9–20. doi: 10.1016/0092-8674(78)90296-9. [DOI] [PubMed] [Google Scholar]
  6. Benham F. J., Boccelli D., Harris H. Suppression and reexpression of human intestinal-like alkaline phosphatase in intraspecific hybrids. Somatic Cell Genet. 1982 Jul;8(4):479–498. doi: 10.1007/BF01538709. [DOI] [PubMed] [Google Scholar]
  7. Berstine E. G., Hooper M. L., Grandchamp S., Ephrussi B. Alkaline phosphatase activity in mouse teratoma. Proc Natl Acad Sci U S A. 1973 Dec;70(12):3899–3903. doi: 10.1073/pnas.70.12.3899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bobrow M., Cross J. Differential staining of human and mouse chromosomes in interspecific cell hybrids. Nature. 1974 Sep 6;251(5470):77–79. doi: 10.1038/251077a0. [DOI] [PubMed] [Google Scholar]
  9. Brinster R. L. The effect of cells transferred into the mouse blastocyst on subsequent development. J Exp Med. 1974 Oct 1;140(4):1049–1056. doi: 10.1084/jem.140.4.1049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cooper A. R., Kurkinen M., Taylor A., Hogan B. L. Studies on the biosynthesis of laminin by murine parietal endoderm cells. Eur J Biochem. 1981 Sep;119(1):189–197. doi: 10.1111/j.1432-1033.1981.tb05593.x. [DOI] [PubMed] [Google Scholar]
  11. Duboule D., Croce C. M., Illmensee K. Tissue preference and differentiation of malignant rat x mouse hybrid cells in chimaeric mouse fetuses. EMBO J. 1982;1(12):1595–1603. doi: 10.1002/j.1460-2075.1982.tb01361.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Finch B. W., Ephrussi B. RETENTION OF MULTIPLE DEVELOPMENTAL POTENTIALITIES BY CELLS OF A MOUSE TESTICULAR TERATOCARCINOMA DURING PROLONGED CULTURE in vitro AND THEIR EXTINCTION UPON HYBRIDIZATION WITH CELLS OF PERMANENT LINES. Proc Natl Acad Sci U S A. 1967 Mar;57(3):615–621. doi: 10.1073/pnas.57.3.615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Fournier R. E., Ruddle F. H. Microcell-mediated transfer of murine chromosomes into mouse, Chinese hamster, and human somatic cells. Proc Natl Acad Sci U S A. 1977 Jan;74(1):319–323. doi: 10.1073/pnas.74.1.319. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Fox N., Damjanov I., Martinez-Hernandez A., Knowles B. B., Solter D. Immunohistochemical localization of the early embryonic antigen (SSEA-1) in postimplantation mouse embryos and fetal and adult tissues. Dev Biol. 1981 Apr 30;83(2):391–398. doi: 10.1016/0012-1606(81)90487-5. [DOI] [PubMed] [Google Scholar]
  15. Gmür R., Solter D., Knowles B. B. Independent regulation of H-2K and H-2D gene expression in murine teratocarcinoma somatic cell hybrids. J Exp Med. 1980 Jun 1;151(6):1349–1359. doi: 10.1084/jem.151.6.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Goodfellow P. N., Banting G., Trowsdale J., Chambers S., Solomon E. Introduction of a human X-6 translocation chromosome into a mouse teratocarcinoma: investigation of control of HLA-A, B, C expression. Proc Natl Acad Sci U S A. 1982 Feb;79(4):1190–1194. doi: 10.1073/pnas.79.4.1190. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Goodfellow P., Banting G., Levy R., Povey S., McMichael A. A human X-linked antigen defined by a monoclonal antibody. Somatic Cell Genet. 1980 Nov;6(6):777–787. doi: 10.1007/BF01538976. [DOI] [PubMed] [Google Scholar]
  18. Heussen C., Dowdle E. B. Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal Biochem. 1980 Feb;102(1):196–202. doi: 10.1016/0003-2697(80)90338-3. [DOI] [PubMed] [Google Scholar]
  19. Hogan B. L., Cooper A. R., Kurkinen M. Incorporation into Reichert's membrane of laminin-like extracellular proteins synthesized by parietal endoderm cells of the mouse embryo. Dev Biol. 1980 Dec;80(2):289–300. doi: 10.1016/0012-1606(80)90405-4. [DOI] [PubMed] [Google Scholar]
  20. Hogan B. L. High molecular weight extracellular proteins synthesized by endoderm cells derived from mouse teratocarcinoma cells and normal extraembryonic membranes. Dev Biol. 1980 May;76(2):275–285. doi: 10.1016/0012-1606(80)90379-6. [DOI] [PubMed] [Google Scholar]
  21. Hogan B. L., Taylor A., Adamson E. Cell interactions modulate embryonal carcinoma cell differentiation into parietal or visceral endoderm. Nature. 1981 May 21;291(5812):235–237. doi: 10.1038/291235a0. [DOI] [PubMed] [Google Scholar]
  22. Howe W. E., Oshima R. G. Coordinate expression of parietal endodermal functions in hybrids of embryonal carcinoma and endodermal cells. Mol Cell Biol. 1982 Mar;2(3):331–337. doi: 10.1128/mcb.2.3.331. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Hyman R., Stallings V. Complementation patterns of Thy-1 variants and evidence that antigen loss variants "pre-exist" in the parental population. J Natl Cancer Inst. 1974 Feb;52(2):429–436. doi: 10.1093/jnci/52.2.429. [DOI] [PubMed] [Google Scholar]
  24. Illmensee K., Croce C. M. Xenogeneic gene expression in chimeric mice derived from rat--mouse hybrid cells. Proc Natl Acad Sci U S A. 1979 Feb;76(2):879–883. doi: 10.1073/pnas.76.2.879. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Illmensee K., Hoppe P. C., Croce C. M. Chimeric mice derived from human-mouse hybrid cells. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1914–1918. doi: 10.1073/pnas.75.4.1914. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Jakob H., Boon T., Gaillard J., Nicolas J., Jacob F. Tératocarcinome de la spuris: isolement, culture et propriétés de cellules a potentialités multiples. Ann Microbiol (Paris) 1973 Oct;124(3):269–282. [PubMed] [Google Scholar]
  27. Jami J., Failly C., Ritz E. Lack of expression of differentiation in mouse teratoma-fibroblast somatic cell hybrids. Exp Cell Res. 1973 Jan;76(1):191–199. doi: 10.1016/0014-4827(73)90435-7. [DOI] [PubMed] [Google Scholar]
  28. Jetten A. M., Jetten M. E., Sherman M. I. Stimulation of differentiation of several murine embryonal carcinoma cell lines by retinoic acid. Exp Cell Res. 1979 Dec;124(2):381–391. doi: 10.1016/0014-4827(79)90213-1. [DOI] [PubMed] [Google Scholar]
  29. Jonasson J., Povey S., Harris H. The analysis of malignancy by cell fusion. VII. Cytogenetic analysis of hybrids between malignant and diploid cells and of tumours derived from them. J Cell Sci. 1977 Apr;24:217–254. doi: 10.1242/jcs.24.1.217. [DOI] [PubMed] [Google Scholar]
  30. Kemler R., Brûlet P., Schnebelen M. T., Gaillard J., Jacob F. Reactivity of monoclonal antibodies against intermediate filament proteins during embryonic development. J Embryol Exp Morphol. 1981 Aug;64:45–60. [PubMed] [Google Scholar]
  31. Knowles B. B., Pan S., Solter D., Linnenbach A., Croce C., Huebner K. Expression of H-2, laminin and SV40 T and TASA on differentiation of transformed murine teratocarcinoma cells. Nature. 1980 Dec 11;288(5791):615–618. doi: 10.1038/288615a0. [DOI] [PubMed] [Google Scholar]
  32. Kucherlapati R., Tepper R., Granelli-Piperno A., Reich E. Modulation and mapping of a human plasminogen activator by cell fusion. Cell. 1978 Dec;15(4):1331–1340. doi: 10.1016/0092-8674(78)90058-2. [DOI] [PubMed] [Google Scholar]
  33. Köhler G., Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975 Aug 7;256(5517):495–497. doi: 10.1038/256495a0. [DOI] [PubMed] [Google Scholar]
  34. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  35. Lehman J. M., Speers W. C., Swartzendruber D. E., Pierce G. B. Neoplastic differentiation: characteristics of cell lines derived from a murine teratocarcinoma. J Cell Physiol. 1974 Aug;84(1):13–27. doi: 10.1002/jcp.1040840103. [DOI] [PubMed] [Google Scholar]
  36. Lemke H., Hämmerling G. J., Hämmerling U. Fine specificity analysis with monoclonal antibodies of antigens controlled by the major histocompatibility complex and by the Qa/TL region in mice. Immunol Rev. 1979;47:175–206. doi: 10.1111/j.1600-065x.1979.tb00293.x. [DOI] [PubMed] [Google Scholar]
  37. Marotti K. R., Belin D., Strickland S. The production of distinct forms of plasminogen activator by mouse embryonic cells. Dev Biol. 1982 Mar;90(1):154–159. doi: 10.1016/0012-1606(82)90220-2. [DOI] [PubMed] [Google Scholar]
  38. Martin G. R., Evans M. J. Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci U S A. 1975 Apr;72(4):1441–1445. doi: 10.1073/pnas.72.4.1441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Martin G. R. Teratocarcinomas and mammalian embryogenesis. Science. 1980 Aug 15;209(4458):768–776. doi: 10.1126/science.6250214. [DOI] [PubMed] [Google Scholar]
  40. Martin G. R. Teratocarcinomas as a model system for the study of embryogenesis and neoplasia. Cell. 1975 Jul;5(3):229–243. doi: 10.1016/0092-8674(75)90098-7. [DOI] [PubMed] [Google Scholar]
  41. McBurney M. W. Clonal lines of teratocarcinoma cells in vitro: differentiation and cytogenetic characteristics. J Cell Physiol. 1976 Nov;89(3):441–455. doi: 10.1002/jcp.1040890310. [DOI] [PubMed] [Google Scholar]
  42. McBurney M. W. Hemoglobin synthesis in cell hybrids formed between teratocarcinoma and Friend erythroleukemia cells. Cell. 1977 Nov;12(3):653–662. doi: 10.1016/0092-8674(77)90265-3. [DOI] [PubMed] [Google Scholar]
  43. Miller R. A., Ruddle F. H. Pluripotent teratocarcinoma-thymus somatic cell hybrids. Cell. 1976 Sep;9(1):45–55. doi: 10.1016/0092-8674(76)90051-9. [DOI] [PubMed] [Google Scholar]
  44. Miller R. A., Ruddle F. H. Teratocarcinoma X friend erythroleukemia cell hybrids resemble their pluripotent embryonal carcinoma parent. Dev Biol. 1977 Mar;56(1):157–173. doi: 10.1016/0012-1606(77)90159-2. [DOI] [PubMed] [Google Scholar]
  45. Mintz B., Illmensee K. Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A. 1975 Sep;72(9):3585–3589. doi: 10.1073/pnas.72.9.3585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Nabholz M., Miggiano V., Bodmer W. Genetic analysis with human--mouse somatic cell hybrids. Nature. 1969 Jul 26;223(5204):358–363. doi: 10.1038/223358a0. [DOI] [PubMed] [Google Scholar]
  47. Papaioannou V. E., McBurney M. W., Gardner R. L., Evans M. J. Fate of teratocarcinoma cells injected into early mouse embryos. Nature. 1975 Nov 6;258(5530):70–73. doi: 10.1038/258070a0. [DOI] [PubMed] [Google Scholar]
  48. Paulin D., Babinet C., Weber K., Osborn M. Antibodies as probes of cellular differentiation and cytoskeletal organization in the mouse blastocyst. Exp Cell Res. 1980 Dec;130(2):297–304. doi: 10.1016/0014-4827(80)90006-3. [DOI] [PubMed] [Google Scholar]
  49. Povey S., Gardiner S. E., Watson B., Mowbray S., Harris H., Arthur E., Steel C. M., Blenkinsop C., Evans H. J. Genetic studies on human lymphoblastoid lines: isozyme analysis on cell lines from forty-one different individuals and on mutants produced following exposure to a chemical mutagen. Ann Hum Genet. 1973 Jan;36(3):247–266. doi: 10.1111/j.1469-1809.1973.tb00588.x. [DOI] [PubMed] [Google Scholar]
  50. Povey S., Jeremiah S., Arthur E., Ber R., Fialkow P. J., Gardiner E., Goodfellow P. N., Karande A., Klein G., Quintero M. Deficiency of malic enzyme: a possible marker for malignancy in lymphoid cells. Ann Hum Genet. 1981 Jul;45(Pt 3):237–252. doi: 10.1111/j.1469-1809.1981.tb00335.x. [DOI] [PubMed] [Google Scholar]
  51. Quinn C. A., Goodfellow P. N., Povey S., Walsh F. S. Human--rat muscle somatic cell hybrids form myotubes and express human muscle gene products. Proc Natl Acad Sci U S A. 1981 Aug;78(8):5031–5035. doi: 10.1073/pnas.78.8.5031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Rousset J. P., Jami J., Dubois P., Avilès D., Ritz E. Developmental potentialities and surface antigens of mouse teratocarcinoma x lymphoid cell hybrids. Somatic Cell Genet. 1980 May;6(3):419–433. doi: 10.1007/BF01542793. [DOI] [PubMed] [Google Scholar]
  53. Sherman M. I., Strickland S., Reich E. Differentiation of early mouse embryonic and teratocarcinoma cells in vitro: plasminogen activator production. Cancer Res. 1976 Nov;36(11 Pt 2):4208–4216. [PubMed] [Google Scholar]
  54. Solter D., Knowles B. B. Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci U S A. 1978 Nov;75(11):5565–5569. doi: 10.1073/pnas.75.11.5565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Solter D., Shevinsky L., Knowles B. B., Strickland S. The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. Dev Biol. 1979 Jun;70(2):515–521. doi: 10.1016/0012-1606(79)90043-5. [DOI] [PubMed] [Google Scholar]
  56. Strickland S., Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 1978 Oct;15(2):393–403. doi: 10.1016/0092-8674(78)90008-9. [DOI] [PubMed] [Google Scholar]
  57. Strickland S., Reich E., Sherman M. I. Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell. 1976 Oct;9(2):231–240. doi: 10.1016/0092-8674(76)90114-8. [DOI] [PubMed] [Google Scholar]
  58. Strickland S., Smith K. K., Marotti K. R. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell. 1980 Sep;21(2):347–355. doi: 10.1016/0092-8674(80)90471-7. [DOI] [PubMed] [Google Scholar]
  59. Vembu D., Young N. S., Willing M., Church E., Sanders-Haigh L., Anderson W. F. Regulation of human globin gene expression in mouse erythroleukemia x human fibroblast hybrid cells. Somatic Cell Genet. 1982 Mar;8(2):163–178. doi: 10.1007/BF01538675. [DOI] [PubMed] [Google Scholar]

Articles from Molecular and Cellular Biology are provided here courtesy of Taylor & Francis

RESOURCES